Skip to main content
. 2020 Jul 7;11:727. doi: 10.3389/fgene.2020.00727

FIGURE 2.

FIGURE 2

The immune score and stromal score are associated with clinicopathologic characteristics and overall survival of cervical cancer patients. (A) Distribution of immune scores and stromal scores among 304 cervical cancer samples in TCGA. (B) Distribution of immune scores among HPV-negative and HPV-positive cases. (C) Distribution of immune scores among cervical cancer subtypes. (D) Distribution of stromal scores among cervical cancer subtypes. (E) A higher immune score is associated with better overall survival (p = 0.02). (F) Stromal score is not associated with overall survival (p = 0.25). TCGA = The Cancer Genome Atlas, GEO = Gene Expression Omnibus, HPV = Human papillomavirus.